Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease

The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as Parkinson's disease (PD). In the pathogenesis of PD, the role of the gut has been previously established. In conjunction with a better und...

Full description

Saved in:
Bibliographic Details
Published inCells (Basel, Switzerland) Vol. 9; no. 2; p. 376
Main Authors Hegelmaier, Tobias, Lebbing, Marco, Duscha, Alexander, Tomaske, Laura, Tönges, Lars, Holm, Jacob Bak, Bjørn Nielsen, Henrik, Gatermann, Sören G, Przuntek, Horst, Haghikia, Aiden
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 06.02.2020
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as Parkinson's disease (PD). In the pathogenesis of PD, the role of the gut has been previously established. In conjunction with a better understanding of the intestinal microbiome, a link to the misfolding and spread of alpha-synuclein via inflammatory processes within the gut is discussed. In a case-control study, we assessed the gut microbiome of 54 PD patients and 32 healthy controls (HC). Additionally, we tested in this proof-of-concept study whether dietary intervention alone or additional physical colon cleaning may lead to changes of the gut microbiome in PD. 16 PD patients underwent a well-controlled balanced, ovo-lacto vegetarian diet intervention including short fatty acids for 14 days. 10 of those patients received additional treatment with daily fecal enema over 8 days. Stool samples were collected before and after 14 days of intervention. In comparison to HC, we could confirm previously reported PD associated microbiome changes. The UDPRS III significantly improved and the levodopa-equivalent daily dose decreased after vegetarian diet and fecal enema in a one-year follow-up. Additionally, we observed a significant association between the gut microbiome diversity and the UPDRS III and the abundance of . Additionally, the abundance of was significantly reduced after enema. Dietary intervention and bowel cleansing may provide an additional non-pharmacologic therapeutic option for PD patients.
AbstractList The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as Parkinson’s disease (PD). In the pathogenesis of PD, the role of the gut has been previously established. In conjunction with a better understanding of the intestinal microbiome, a link to the misfolding and spread of alpha-synuclein via inflammatory processes within the gut is discussed. In a case-control study, we assessed the gut microbiome of 54 PD patients and 32 healthy controls (HC). Additionally, we tested in this proof-of-concept study whether dietary intervention alone or additional physical colon cleaning may lead to changes of the gut microbiome in PD. 16 PD patients underwent a well-controlled balanced, ovo-lacto vegetarian diet intervention including short fatty acids for 14 days. 10 of those patients received additional treatment with daily fecal enema over 8 days. Stool samples were collected before and after 14 days of intervention. In comparison to HC, we could confirm previously reported PD associated microbiome changes. The UDPRS III significantly improved and the levodopa-equivalent daily dose decreased after vegetarian diet and fecal enema in a one-year follow-up. Additionally, we observed a significant association between the gut microbiome diversity and the UPDRS III and the abundance of Ruminococcaceae . Additionally, the abundance of Clostridiaceae was significantly reduced after enema. Dietary intervention and bowel cleansing may provide an additional non-pharmacologic therapeutic option for PD patients.
The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as Parkinson's disease (PD). In the pathogenesis of PD, the role of the gut has been previously established. In conjunction with a better understanding of the intestinal microbiome, a link to the misfolding and spread of alpha-synuclein via inflammatory processes within the gut is discussed. In a case-control study, we assessed the gut microbiome of 54 PD patients and 32 healthy controls (HC). Additionally, we tested in this proof-of-concept study whether dietary intervention alone or additional physical colon cleaning may lead to changes of the gut microbiome in PD. 16 PD patients underwent a well-controlled balanced, ovo-lacto vegetarian diet intervention including short fatty acids for 14 days. 10 of those patients received additional treatment with daily fecal enema over 8 days. Stool samples were collected before and after 14 days of intervention. In comparison to HC, we could confirm previously reported PD associated microbiome changes. The UDPRS III significantly improved and the levodopa-equivalent daily dose decreased after vegetarian diet and fecal enema in a one-year follow-up. Additionally, we observed a significant association between the gut microbiome diversity and the UPDRS III and the abundance of Ruminococcaceae. Additionally, the abundance of Clostridiaceae was significantly reduced after enema. Dietary intervention and bowel cleansing may provide an additional non-pharmacologic therapeutic option for PD patients.
The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as Parkinson's disease (PD). In the pathogenesis of PD, the role of the gut has been previously established. In conjunction with a better understanding of the intestinal microbiome, a link to the misfolding and spread of alpha-synuclein via inflammatory processes within the gut is discussed. In a case-control study, we assessed the gut microbiome of 54 PD patients and 32 healthy controls (HC). Additionally, we tested in this proof-of-concept study whether dietary intervention alone or additional physical colon cleaning may lead to changes of the gut microbiome in PD. 16 PD patients underwent a well-controlled balanced, ovo-lacto vegetarian diet intervention including short fatty acids for 14 days. 10 of those patients received additional treatment with daily fecal enema over 8 days. Stool samples were collected before and after 14 days of intervention. In comparison to HC, we could confirm previously reported PD associated microbiome changes. The UDPRS III significantly improved and the levodopa-equivalent daily dose decreased after vegetarian diet and fecal enema in a one-year follow-up. Additionally, we observed a significant association between the gut microbiome diversity and the UPDRS III and the abundance of . Additionally, the abundance of was significantly reduced after enema. Dietary intervention and bowel cleansing may provide an additional non-pharmacologic therapeutic option for PD patients.
Author Lebbing, Marco
Duscha, Alexander
Bjørn Nielsen, Henrik
Tomaske, Laura
Tönges, Lars
Holm, Jacob Bak
Przuntek, Horst
Gatermann, Sören G
Haghikia, Aiden
Hegelmaier, Tobias
AuthorAffiliation 4 Department of Medical Microbiology, Ruhr-University Bochum, Bochum, 44801, Germany; soeren.gatermann@rub.de
2 Clinic of Neurology II, EVK Hattingen, Hattingen 45525, Germany; marco.lebbing@googlemail.com (M.L.); przuntekh@t-online.de (H.P.)
3 Clinical Microbiomics A/S, Copenhagen 2200, Denmark; jacob@clinical-microbiomics.com (J.B.H.); hbjorn@clinical-microbiomics.com (H.B.N.)
1 Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany; tobias.hegelmaier@googlemail.com (T.H.); Alexander.Duscha@ruhr-uni-bochum.de (A.D.); Laura.Ackermann@ruhr-uni-bochum.de (L.T.); lars.toenges@rub.de (L.T.)
AuthorAffiliation_xml – name: 1 Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany; tobias.hegelmaier@googlemail.com (T.H.); Alexander.Duscha@ruhr-uni-bochum.de (A.D.); Laura.Ackermann@ruhr-uni-bochum.de (L.T.); lars.toenges@rub.de (L.T.)
– name: 4 Department of Medical Microbiology, Ruhr-University Bochum, Bochum, 44801, Germany; soeren.gatermann@rub.de
– name: 3 Clinical Microbiomics A/S, Copenhagen 2200, Denmark; jacob@clinical-microbiomics.com (J.B.H.); hbjorn@clinical-microbiomics.com (H.B.N.)
– name: 2 Clinic of Neurology II, EVK Hattingen, Hattingen 45525, Germany; marco.lebbing@googlemail.com (M.L.); przuntekh@t-online.de (H.P.)
Author_xml – sequence: 1
  givenname: Tobias
  surname: Hegelmaier
  fullname: Hegelmaier, Tobias
  organization: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany
– sequence: 2
  givenname: Marco
  surname: Lebbing
  fullname: Lebbing, Marco
  organization: Clinic of Neurology II, EVK Hattingen, Hattingen 45525, Germany
– sequence: 3
  givenname: Alexander
  surname: Duscha
  fullname: Duscha, Alexander
  organization: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany
– sequence: 4
  givenname: Laura
  surname: Tomaske
  fullname: Tomaske, Laura
  organization: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany
– sequence: 5
  givenname: Lars
  surname: Tönges
  fullname: Tönges, Lars
  organization: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany
– sequence: 6
  givenname: Jacob Bak
  surname: Holm
  fullname: Holm, Jacob Bak
  organization: Clinical Microbiomics A/S, Copenhagen 2200, Denmark
– sequence: 7
  givenname: Henrik
  surname: Bjørn Nielsen
  fullname: Bjørn Nielsen, Henrik
  organization: Clinical Microbiomics A/S, Copenhagen 2200, Denmark
– sequence: 8
  givenname: Sören G
  surname: Gatermann
  fullname: Gatermann, Sören G
  organization: Department of Medical Microbiology, Ruhr-University Bochum, Bochum, 44801, Germany
– sequence: 9
  givenname: Horst
  surname: Przuntek
  fullname: Przuntek, Horst
  organization: Clinic of Neurology II, EVK Hattingen, Hattingen 45525, Germany
– sequence: 10
  givenname: Aiden
  surname: Haghikia
  fullname: Haghikia, Aiden
  organization: Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital Bochum, Bochum, 44791, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32041265$$D View this record in MEDLINE/PubMed
BookMark eNpVkstu1DAUhi1UREvpjjXyDhYd8DV2Nkgw5RKpFUiUteVJTjIuiT21nUF9FZ4WD1OqqTe2_P_-js_lOTrywQNCLyl5y3lN3rUwjqkmjHBVPUEnjCi-EILURwfnY3SW0g0pS9OKEvkMHXNGBGWVPEF_Gp8hbsFnF7wdceP7cQbfAg49zmvAOz1lt9OuXBvDyoUJ8PU6hnlY4wsH2cY7fEjB1nf4Y_gNI16OYH1yfihvh3XGzbSJYQv4KuQQ8Y-7aZPDlLDz-LuNv5xPwb9OBZrAJniBnvZ2THB2v5-in58_XS-_Li6_fWmWHy4XrZAkLzTtVcVB1qta6arSrSCMtQRKqqQFZSXrQTLLtVJM9RZ6yZVVda-ZlpR3lJ-iZs_tgr0xm-imkpEJ1pl_FyEOxsbs2hEMk6LqBDBChRAgoa5JCcbFiioqtFaF9X7P2syrCbq2VCTa8RH0seLd2gxhaxRRjClZAG_uATHczqXyZnJp12XrIczJMC65VJqxuljP99bSlZQi9A9hKDG76TCH01Hsrw6_9mD-Pwv8L9PfuXM
CitedBy_id crossref_primary_10_1155_2022_9895499
crossref_primary_10_1080_1028415X_2023_2233727
crossref_primary_10_4103_1673_5374_391191
crossref_primary_10_1007_s40263_024_01073_4
crossref_primary_10_1080_1028415X_2022_2073107
crossref_primary_10_51248__v42i3_1639
crossref_primary_10_3389_fmed_2024_1408609
crossref_primary_10_1016_j_jpsychores_2022_110942
crossref_primary_10_1007_s12035_024_04318_x
crossref_primary_10_3389_fnagi_2022_875261
crossref_primary_10_1055_a_1660_6418
crossref_primary_10_3390_nu14194108
crossref_primary_10_1093_braincomms_fcab113
crossref_primary_10_1007_s00702_021_02457_2
crossref_primary_10_3389_fneur_2023_1185375
crossref_primary_10_1128_spectrum_02047_21
crossref_primary_10_1016_j_clnu_2024_05_036
crossref_primary_10_4103_ijoy_ijoy_186_21
crossref_primary_10_1016_j_coche_2021_100673
crossref_primary_10_3390_biomedicines10020436
crossref_primary_10_3390_jpm12010049
crossref_primary_10_3390_ijms24119577
crossref_primary_10_1016_j_explore_2023_05_001
crossref_primary_10_3390_biom11030433
crossref_primary_10_1128_CMR_00338_20
crossref_primary_10_1007_s12223_022_00977_2
crossref_primary_10_3389_fnagi_2022_917499
crossref_primary_10_1016_j_neubiorev_2021_02_044
crossref_primary_10_1186_s40168_023_01475_4
crossref_primary_10_3390_biomedicines11102793
crossref_primary_10_3390_cells13090770
crossref_primary_10_1111_jdv_18006
crossref_primary_10_3389_fnins_2023_1268419
crossref_primary_10_3233_JPD_230264
crossref_primary_10_32604_biocell_2021_013452
crossref_primary_10_1016_j_nbd_2022_105695
crossref_primary_10_1016_j_brainresbull_2024_110989
crossref_primary_10_1007_s13311_020_00942_2
crossref_primary_10_1016_j_phrs_2021_105840
crossref_primary_10_3390_ijms23147503
crossref_primary_10_3390_ijms22189839
crossref_primary_10_1016_j_lfs_2024_122413
crossref_primary_10_3389_fnagi_2022_1020172
crossref_primary_10_1038_s41582_022_00681_2
crossref_primary_10_1080_14728222_2020_1763956
crossref_primary_10_3390_life11070698
crossref_primary_10_3390_metabo13030416
crossref_primary_10_3389_fneur_2024_1415463
crossref_primary_10_3389_fneur_2021_729961
crossref_primary_10_3390_nu14214472
crossref_primary_10_1089_photob_2021_0056
crossref_primary_10_1016_j_neuropharm_2023_109566
crossref_primary_10_1093_nutrit_nuab024
crossref_primary_10_3390_foods12061151
crossref_primary_10_1038_s41598_024_59250_w
crossref_primary_10_1177_08919887211018268
crossref_primary_10_1007_s13668_024_00539_7
crossref_primary_10_2147_JPR_S415642
crossref_primary_10_3390_cells12010157
crossref_primary_10_3389_fphar_2024_1388401
crossref_primary_10_3390_ijms21207471
crossref_primary_10_1177_17562848231174298
crossref_primary_10_1016_j_brainres_2021_147609
Cites_doi 10.1186/s12866-016-0708-5
10.1007/s12035-018-0937-8
10.1093/nar/gkt1244
10.1038/s41575-019-0157-3
10.1017/S0029665120001251
10.1002/mds.26942
10.1002/mds.26563
10.1007/s00702-002-0808-2
10.1016/0278-5846(94)90074-4
10.3390/nu10050576
10.3389/fneur.2019.00574
10.1128/mSystems.00130-17
10.1038/nmeth.2604
10.1074/jbc.M211609200
10.1177/014860719902300518
10.1371/journal.pone.0032545
10.1016/j.tim.2016.09.011
10.1002/mds.27326
10.1128/AEM.00062-07
10.1038/nrmicro3344
10.1038/ismej.2012.104
10.1002/mds.26712
10.1371/journal.pone.0028032
10.1002/mds.25150
10.1093/bioinformatics/btr381
10.1038/nature11053
10.1186/s40478-015-0196-0
10.1007/s13311-017-0598-8
10.1016/j.cell.2016.11.018
10.1128/AEM.01541-09
10.1016/j.neuint.2016.06.011
10.1002/ana.24448
10.1186/s12967-017-1175-y
10.1371/journal.pone.0142164
10.1128/mBio.01294-18
10.1002/mds.25020
10.1002/oby.20466
10.3109/00365529709011203
10.1038/s41598-019-40182-9
10.1016/j.parkreldis.2018.02.022
10.1016/j.nbd.2012.09.007
10.1186/s12866-019-1557-9
10.3748/wjg.v17.i12.1519
10.1038/nature08821
10.1210/jc.2016-1797
10.1038/s41531-016-0002-0
10.1002/mds.10248
10.1371/journal.pone.0055817
10.1038/ctg.2015.54
10.1016/j.cell.2016.01.013
10.1038/s41467-019-08294-y
10.1097/MIB.0000000000000735
10.4291/wjgp.v5.i4.400
10.1111/j.1468-1331.2008.02056.x
10.1002/mds.26307
10.1016/j.immuni.2015.09.007
10.1093/aje/kwh213
10.1016/j.foodchem.2012.06.013
10.1016/j.parkreldis.2016.08.019
10.1111/imm.12645
10.1016/j.neulet.2008.06.040
10.1016/j.brainres.2017.04.019
10.1007/s10517-017-3700-7
10.3389/fnins.2019.00992
10.1186/s40168-018-0439-y
10.1155/2017/9351507
10.1016/j.chom.2015.03.005
10.1586/ern.11.192
10.1126/science.aau6323
10.1007/s00702-015-1463-8
10.1523/JNEUROSCI.5002-13.2014
10.20944/preprints201804.0370.v1
10.1097/MEG.0000000000000581
10.1212/WNL.0000000000003961
10.3389/fphar.2018.01354
10.7717/peerj.3019
10.1007/s00415-012-6801-2
ContentType Journal Article
Copyright 2020 by the authors. 2020
Copyright_xml – notice: 2020 by the authors. 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/cells9020376
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2073-4409
ExternalDocumentID oai_doaj_org_article_2546d4e201444e5e99002234b1714887
10_3390_cells9020376
32041265
Genre Clinical Trial
Journal Article
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
ABDBF
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CGR
CUY
CVF
DIK
EBD
ECM
EIF
ESX
GROUPED_DOAJ
HCIFZ
HYE
IAO
IHR
KQ8
LK8
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PROAC
RIG
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c450t-81f763e59b978668c4022c0e6100ce7a52fe52a387727faef537a79f828513d13
IEDL.DBID RPM
ISSN 2073-4409
IngestDate Fri Oct 04 13:12:25 EDT 2024
Tue Sep 17 21:14:51 EDT 2024
Sat Aug 17 01:29:50 EDT 2024
Fri Aug 23 04:51:57 EDT 2024
Sat Sep 28 08:24:50 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords vegetarian diet
butyric acid
enema
microbiome
Parkinson’s disease
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c450t-81f763e59b978668c4022c0e6100ce7a52fe52a387727faef537a79f828513d13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
These authors contributed equally to this work.
ORCID 0000-0001-6621-144X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072275/
PMID 32041265
PQID 2353578229
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_2546d4e201444e5e99002234b1714887
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7072275
proquest_miscellaneous_2353578229
crossref_primary_10_3390_cells9020376
pubmed_primary_32041265
PublicationCentury 2000
PublicationDate 2020-02-06
PublicationDateYYYYMMDD 2020-02-06
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-06
  day: 06
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Cells (Basel, Switzerland)
PublicationTitleAlternate Cells
PublicationYear 2020
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Clairembault (ref_25) 2015; 3
Sampson (ref_30) 2016; 167
Frye (ref_31) 2019; 10
Nagata (ref_73) 2019; 9
ref_57
Vorovenci (ref_75) 2016; 123
Chen (ref_50) 2004; 160
Suchowersky (ref_26) 2012; 12
Houser (ref_41) 2017; 3
Unger (ref_7) 2016; 32
Shobar (ref_70) 2016; 7
(ref_19) 2014; 5
Shannon (ref_14) 2012; 27
Stilling (ref_67) 2016; 99
Keshavarzian (ref_8) 2015; 30
Feng (ref_53) 2018; 9
Santos (ref_17) 2019; 10
Schloss (ref_36) 2009; 75
Qin (ref_12) 2010; 464
Wang (ref_39) 2007; 73
Braak (ref_13) 2003; 110
Erny (ref_66) 2017; 150
Poewe (ref_1) 2008; 15
Dalile (ref_65) 2019; 16
Wong (ref_55) 2018; 30
ref_69
Cersosimo (ref_3) 2013; 260
Canani (ref_60) 2011; 17
Petrov (ref_5) 2017; 162
Hopfner (ref_9) 2017; 1667
Lewis (ref_33) 1997; 32
Haghikia (ref_61) 2015; 43
Svensson (ref_15) 2015; 78
Ramaker (ref_34) 2002; 17
ref_27
Nonnekes (ref_76) 2016; 31
Andoh (ref_43) 1999; 23
Derrien (ref_54) 2017; 25
Drago (ref_71) 2016; 28
Schwiertz (ref_21) 2018; 50
Andrewes (ref_68) 2012; 135
ref_72
Kieburtz (ref_2) 2013; 28
Goffredo (ref_52) 2016; 101
Debelius (ref_4) 2017; 32
ref_78
ref_32
ref_74
Yatsunenko (ref_46) 2012; 486
Houser (ref_23) 2018; 33
Cox (ref_40) 2018; 15
Greenblatt (ref_51) 1994; 18
Hoyles (ref_63) 2018; 6
Rizzatti (ref_44) 2017; 2017
Bodea (ref_18) 2014; 34
Lin (ref_20) 2016; 22
Singh (ref_59) 2017; 15
Sender (ref_10) 2016; 164
Verdam (ref_58) 2013; 21
ref_47
Louis (ref_62) 2014; 12
ref_45
Brodacki (ref_29) 2008; 441
ref_42
Lattimer (ref_56) 2013; 7
Guerra (ref_11) 2018; 55
Brown (ref_64) 2003; 278
Mulak (ref_22) 2019; 13
Bermingham (ref_77) 2017; 5
Devos (ref_24) 2013; 50
Wijeyekoon (ref_28) 2016; 31
Liu (ref_16) 2017; 88
Cole (ref_37) 2014; 42
ref_49
Edgar (ref_35) 2013; 10
Kelly (ref_48) 2015; 17
Edgar (ref_38) 2011; 27
ref_6
References_xml – ident: ref_78
  doi: 10.1186/s12866-016-0708-5
– volume: 55
  start-page: 7297
  year: 2018
  ident: ref_11
  article-title: Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-018-0937-8
  contributor:
    fullname: Guerra
– volume: 42
  start-page: D633
  year: 2014
  ident: ref_37
  article-title: Ribosomal Database Project: Data and tools for high throughput rRNA analysis
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt1244
  contributor:
    fullname: Cole
– volume: 16
  start-page: 461
  year: 2019
  ident: ref_65
  article-title: The role of short-chain fatty acids in microbiota-gut-brain communication
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-019-0157-3
  contributor:
    fullname: Dalile
– ident: ref_47
  doi: 10.1017/S0029665120001251
– volume: 32
  start-page: 739
  year: 2017
  ident: ref_4
  article-title: Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26942
  contributor:
    fullname: Debelius
– volume: 31
  start-page: 995
  year: 2016
  ident: ref_28
  article-title: Serum immune markers and disease progression in an incident Parkinson’s disease cohort (ICICLE-PD)
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26563
  contributor:
    fullname: Wijeyekoon
– volume: 110
  start-page: 517
  year: 2003
  ident: ref_13
  article-title: Idiopathic Parkinson’s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
  publication-title: J. Neural Transm. (Vienna)
  doi: 10.1007/s00702-002-0808-2
  contributor:
    fullname: Braak
– volume: 18
  start-page: 647
  year: 1994
  ident: ref_51
  article-title: Folic acid in neurodevelopment and child psychiatry
  publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry
  doi: 10.1016/0278-5846(94)90074-4
  contributor:
    fullname: Greenblatt
– ident: ref_57
  doi: 10.3390/nu10050576
– volume: 10
  start-page: 574
  year: 2019
  ident: ref_17
  article-title: The Gut and Parkinson’s Disease-A Bidirectional Pathway
  publication-title: Front. Neurol.
  doi: 10.3389/fneur.2019.00574
  contributor:
    fullname: Santos
– ident: ref_42
  doi: 10.1128/mSystems.00130-17
– volume: 10
  start-page: 996
  year: 2013
  ident: ref_35
  article-title: UPARSE: Highly accurate OTU sequences from microbial amplicon reads
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2604
  contributor:
    fullname: Edgar
– volume: 278
  start-page: 11312
  year: 2003
  ident: ref_64
  article-title: The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M211609200
  contributor:
    fullname: Brown
– volume: 23
  start-page: S70
  year: 1999
  ident: ref_43
  article-title: Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions
  publication-title: JPEN J. Parenter Enteral Nutr.
  doi: 10.1177/014860719902300518
  contributor:
    fullname: Andoh
– ident: ref_72
  doi: 10.1371/journal.pone.0032545
– volume: 25
  start-page: 100
  year: 2017
  ident: ref_54
  article-title: Rethinking Diet to Aid Human-Microbe Symbiosis
  publication-title: Trends Microbiol.
  doi: 10.1016/j.tim.2016.09.011
  contributor:
    fullname: Derrien
– volume: 33
  start-page: 793
  year: 2018
  ident: ref_23
  article-title: Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson’s Disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.27326
  contributor:
    fullname: Houser
– volume: 73
  start-page: 5261
  year: 2007
  ident: ref_39
  article-title: Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.00062-07
  contributor:
    fullname: Wang
– volume: 12
  start-page: 661
  year: 2014
  ident: ref_62
  article-title: The gut microbiota, bacterial metabolites and colorectal cancer
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro3344
  contributor:
    fullname: Louis
– volume: 7
  start-page: 269
  year: 2013
  ident: ref_56
  article-title: Gut microbiome composition is linked to whole grain-induced immunological improvements
  publication-title: ISME J.
  doi: 10.1038/ismej.2012.104
  contributor:
    fullname: Lattimer
– volume: 31
  start-page: 1602
  year: 2016
  ident: ref_76
  article-title: Unmasking levodopa resistance in Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26712
  contributor:
    fullname: Nonnekes
– ident: ref_27
  doi: 10.1371/journal.pone.0028032
– volume: 28
  start-page: 8
  year: 2013
  ident: ref_2
  article-title: Parkinson’s disease: Evidence for environmental risk factors
  publication-title: Mov. Disord. Off. J. Mov. Disord. Soc.
  doi: 10.1002/mds.25150
  contributor:
    fullname: Kieburtz
– volume: 27
  start-page: 2194
  year: 2011
  ident: ref_38
  article-title: UCHIME improves sensitivity and speed of chimera detection
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr381
  contributor:
    fullname: Edgar
– volume: 486
  start-page: 222
  year: 2012
  ident: ref_46
  article-title: Human gut microbiome viewed across age and geography
  publication-title: Nature
  doi: 10.1038/nature11053
  contributor:
    fullname: Yatsunenko
– volume: 3
  start-page: 12
  year: 2015
  ident: ref_25
  article-title: Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
  publication-title: Acta Neuropathol. Commun.
  doi: 10.1186/s40478-015-0196-0
  contributor:
    fullname: Clairembault
– volume: 15
  start-page: 135
  year: 2018
  ident: ref_40
  article-title: Microbiota Signaling Pathways that Influence Neurologic Disease
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-017-0598-8
  contributor:
    fullname: Cox
– volume: 167
  start-page: 1469
  year: 2016
  ident: ref_30
  article-title: Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
  publication-title: Cell
  doi: 10.1016/j.cell.2016.11.018
  contributor:
    fullname: Sampson
– volume: 75
  start-page: 7537
  year: 2009
  ident: ref_36
  article-title: Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.01541-09
  contributor:
    fullname: Schloss
– volume: 99
  start-page: 110
  year: 2016
  ident: ref_67
  article-title: The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2016.06.011
  contributor:
    fullname: Stilling
– volume: 78
  start-page: 522
  year: 2015
  ident: ref_15
  article-title: Vagotomy and subsequent risk of Parkinson’s disease
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24448
  contributor:
    fullname: Svensson
– volume: 15
  start-page: 73
  year: 2017
  ident: ref_59
  article-title: Influence of diet on the gut microbiome and implications for human health
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-017-1175-y
  contributor:
    fullname: Singh
– ident: ref_6
  doi: 10.1371/journal.pone.0142164
– ident: ref_74
  doi: 10.1128/mBio.01294-18
– volume: 27
  start-page: 716
  year: 2012
  ident: ref_14
  article-title: Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases
  publication-title: Mov. Disord. Off. J. Mov. Disord. Soc.
  doi: 10.1002/mds.25020
  contributor:
    fullname: Shannon
– volume: 21
  start-page: E607
  year: 2013
  ident: ref_58
  article-title: Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.20466
  contributor:
    fullname: Verdam
– volume: 32
  start-page: 920
  year: 1997
  ident: ref_33
  article-title: Stool form scale as a useful guide to intestinal transit time
  publication-title: Scand. J. Gastroenterol.
  doi: 10.3109/00365529709011203
  contributor:
    fullname: Lewis
– volume: 9
  start-page: 4042
  year: 2019
  ident: ref_73
  article-title: Effects of bowel preparation on the human gut microbiome and metabolome
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-40182-9
  contributor:
    fullname: Nagata
– volume: 50
  start-page: 104
  year: 2018
  ident: ref_21
  article-title: Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson’s disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2018.02.022
  contributor:
    fullname: Schwiertz
– volume: 50
  start-page: 42
  year: 2013
  ident: ref_24
  article-title: Colonic inflammation in Parkinson’s disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2012.09.007
  contributor:
    fullname: Devos
– ident: ref_45
  doi: 10.1186/s12866-019-1557-9
– volume: 17
  start-page: 1519
  year: 2011
  ident: ref_60
  article-title: Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i12.1519
  contributor:
    fullname: Canani
– volume: 464
  start-page: 59
  year: 2010
  ident: ref_12
  article-title: A human gut microbial gene catalogue established by metagenomic sequencing
  publication-title: Nature
  doi: 10.1038/nature08821
  contributor:
    fullname: Qin
– volume: 101
  start-page: 4367
  year: 2016
  ident: ref_52
  article-title: Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2016-1797
  contributor:
    fullname: Goffredo
– volume: 3
  start-page: 3
  year: 2017
  ident: ref_41
  article-title: The gut-brain axis: Is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
  publication-title: NPJ Parkinsons Dis.
  doi: 10.1038/s41531-016-0002-0
  contributor:
    fullname: Houser
– volume: 17
  start-page: 867
  year: 2002
  ident: ref_34
  article-title: Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.10248
  contributor:
    fullname: Ramaker
– ident: ref_69
  doi: 10.1371/journal.pone.0055817
– volume: 7
  start-page: e143
  year: 2016
  ident: ref_70
  article-title: The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments
  publication-title: Clin. Transl. Gastroenterol.
  doi: 10.1038/ctg.2015.54
  contributor:
    fullname: Shobar
– volume: 30
  start-page: 200
  year: 2018
  ident: ref_55
  article-title: Impact of vegan diets on gut microbiota: An update on the clinical implications
  publication-title: Ci Ji Yi Xue Za Zhi
  contributor:
    fullname: Wong
– volume: 164
  start-page: 337
  year: 2016
  ident: ref_10
  article-title: Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.013
  contributor:
    fullname: Sender
– volume: 10
  start-page: 310
  year: 2019
  ident: ref_31
  article-title: Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-08294-y
  contributor:
    fullname: Frye
– volume: 22
  start-page: 1049
  year: 2016
  ident: ref_20
  article-title: Association Between Parkinson’s Disease and Inflammatory Bowel Disease: A Nationwide Taiwanese Retrospective Cohort Study
  publication-title: Inflamm. Bowel Dis.
  doi: 10.1097/MIB.0000000000000735
  contributor:
    fullname: Lin
– volume: 5
  start-page: 400
  year: 2014
  ident: ref_19
  article-title: Helicobacter pylori and neurological diseases: Married by the laws of inflammation
  publication-title: World J. Gastrointest. Pathophysiol.
  doi: 10.4291/wjgp.v5.i4.400
– volume: 15
  start-page: 14
  year: 2008
  ident: ref_1
  article-title: Non-motor symptoms in Parkinson’s disease
  publication-title: Eur. J. Neurol.
  doi: 10.1111/j.1468-1331.2008.02056.x
  contributor:
    fullname: Poewe
– volume: 30
  start-page: 1351
  year: 2015
  ident: ref_8
  article-title: Colonic bacterial composition in Parkinson’s disease
  publication-title: Mov. Disord.
  doi: 10.1002/mds.26307
  contributor:
    fullname: Keshavarzian
– volume: 43
  start-page: 817
  year: 2015
  ident: ref_61
  article-title: Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.09.007
  contributor:
    fullname: Haghikia
– volume: 160
  start-page: 368
  year: 2004
  ident: ref_50
  article-title: Folate intake and risk of Parkinson’s disease
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwh213
  contributor:
    fullname: Chen
– volume: 135
  start-page: 921
  year: 2012
  ident: ref_68
  article-title: Changes in Maillard reaction products in ghee during storage
  publication-title: Food Chem.
  doi: 10.1016/j.foodchem.2012.06.013
  contributor:
    fullname: Andrewes
– volume: 32
  start-page: 66
  year: 2016
  ident: ref_7
  article-title: Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2016.08.019
  contributor:
    fullname: Unger
– volume: 150
  start-page: 7
  year: 2017
  ident: ref_66
  article-title: Communicating systems in the body: How microbiota and microglia cooperate
  publication-title: Immunology
  doi: 10.1111/imm.12645
  contributor:
    fullname: Erny
– volume: 441
  start-page: 158
  year: 2008
  ident: ref_29
  article-title: Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2008.06.040
  contributor:
    fullname: Brodacki
– volume: 1667
  start-page: 41
  year: 2017
  ident: ref_9
  article-title: Gut microbiota in Parkinson disease in a northern German cohort
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2017.04.019
  contributor:
    fullname: Hopfner
– volume: 162
  start-page: 734
  year: 2017
  ident: ref_5
  article-title: Analysis of Gut Microbiota in Patients with Parkinson’s Disease
  publication-title: Bull. Exp. Biol. Med.
  doi: 10.1007/s10517-017-3700-7
  contributor:
    fullname: Petrov
– volume: 13
  start-page: 992
  year: 2019
  ident: ref_22
  article-title: Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
  publication-title: Front. Neurosci.
  doi: 10.3389/fnins.2019.00992
  contributor:
    fullname: Mulak
– volume: 6
  start-page: 55
  year: 2018
  ident: ref_63
  article-title: Microbiome-host systems interactions: Protective effects of propionate upon the blood-brain barrier
  publication-title: Microbiome
  doi: 10.1186/s40168-018-0439-y
  contributor:
    fullname: Hoyles
– volume: 2017
  start-page: 9351507
  year: 2017
  ident: ref_44
  article-title: Proteobacteria: A Common Factor in Human Diseases
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2017/9351507
  contributor:
    fullname: Rizzatti
– volume: 17
  start-page: 662
  year: 2015
  ident: ref_48
  article-title: Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2015.03.005
  contributor:
    fullname: Kelly
– volume: 12
  start-page: 239
  year: 2012
  ident: ref_26
  article-title: The management of gastrointestinal symptoms in Parkinson’s disease
  publication-title: Expert Rev. Neurother.
  doi: 10.1586/ern.11.192
  contributor:
    fullname: Suchowersky
– ident: ref_32
  doi: 10.1126/science.aau6323
– volume: 123
  start-page: 19
  year: 2016
  ident: ref_75
  article-title: Therapy-resistant symptoms in Parkinson’s disease
  publication-title: J. Neural Transm. (Vienna)
  doi: 10.1007/s00702-015-1463-8
  contributor:
    fullname: Vorovenci
– volume: 34
  start-page: 8546
  year: 2014
  ident: ref_18
  article-title: Neurodegeneration by activation of the microglial complement-phagosome pathway
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5002-13.2014
  contributor:
    fullname: Bodea
– ident: ref_49
  doi: 10.20944/preprints201804.0370.v1
– volume: 28
  start-page: 532
  year: 2016
  ident: ref_71
  article-title: Persisting changes of intestinal microbiota after bowel lavage and colonoscopy
  publication-title: Eur J. Gastroenterol. Hepatol.
  doi: 10.1097/MEG.0000000000000581
  contributor:
    fullname: Drago
– volume: 88
  start-page: 1996
  year: 2017
  ident: ref_16
  article-title: Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000003961
  contributor:
    fullname: Liu
– volume: 9
  start-page: 1354
  year: 2018
  ident: ref_53
  article-title: Gut Microbiota, Short-Chain Fatty Acids and Herbal Medicines
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2018.01354
  contributor:
    fullname: Feng
– volume: 5
  start-page: e3019
  year: 2017
  ident: ref_77
  article-title: Key bacterial families (Clostridiaceae, Erysipelotrichaceae and Bacteroidaceae) are related to the digestion of protein and energy in dogs
  publication-title: PeerJ
  doi: 10.7717/peerj.3019
  contributor:
    fullname: Bermingham
– volume: 260
  start-page: 1332
  year: 2013
  ident: ref_3
  article-title: Gastrointestinal manifestations in Parkinson’s disease: Prevalence and occurrence before motor symptoms
  publication-title: J. Neurol.
  doi: 10.1007/s00415-012-6801-2
  contributor:
    fullname: Cersosimo
SSID ssj0000816105
Score 2.4311376
Snippet The impact of the gut microbiome is being increasingly appreciated in health and in various chronic diseases, among them neurodegenerative disorders such as...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 376
SubjectTerms Bacteria - drug effects
butyric acid
Case-Control Studies
Cathartics - pharmacology
Diet
enema
Female
Gastrointestinal Microbiome - drug effects
Humans
Levodopa - pharmacology
Levodopa - therapeutic use
Male
microbiome
Middle Aged
Motor Activity - drug effects
Parkinson Disease - drug therapy
Parkinson Disease - microbiology
Parkinson Disease - physiopathology
parkinson’s disease
Phylogeny
Principal Component Analysis
vegetarian diet
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NatwwEBYlUOiltOmf06So0B5NbP1Y9rFJG5LC9tIEcjOSNaILWTtkHcre-hqFPl2fJDPSbvCWQi_10ZJloRlpvpFG3zD2DkGnVqXTuQtdyJU3IW-873LtvKsK72wdebZnX6rTC_X5Ul9OUn1RTFiiB04Dd0h87V6BIOSvQAOunmh2pHKUuRtnSFx9Sz1xpuIaXCOSKXSKdJfo1x_SPviyoXM3oheZ2KBI1f83fPlnmOTE7pw8YY_XgJF_SB19yh5Av8sephSSq2fs19kkaBHrnW2SjvAhcAR3nMpxGlPZbJ5YlxbAz1N6Hv5xDqO9WfFpK9z2nh8N3-GKH18BmjK0bvgtOvE8bUEAnw3oqvOvq8X1OCyWfN5zuj0dL5L9_vFzic3GY5_n7OLk0_nxab7OuJB3ShdjXpcB1xvQjUPnsqrqDr1L0RWAY1l0YKwWAbSwskZMboKFoKWxpglEg1dKX8oXbKcfenjFeOclvre6kQFBi1K2aIKtHT5BlV51GXu_kUF7nYg1WnRISFbtVFYZOyIB3dchOuz4ApWkXStJ-y8lydjbjXhbnD7Uvu1huF22Qmri-xGiydjLJO77X0lBZGSVzpjZUoStvmyX9PNvkaLbFEYIo_f-R-dfs0eCnHwKFa_22c54cwsHiIRG9yYq_R12fwmj
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlAviDfhJSPBMZD4EScHhGihapGWC12pt8iJbVhpNymbVLA3_gYSv45fwkweVRZ6Isc4dqyM7fk-e_INwHMEnUrGhQoLX_pQWu3DzNoyVIUtksgWJu10tmcfk6O5_HCqTndgzDY6fMDmUmpH-aTm6-XL7183b3DCvybGiZT9FW1xNxkdqenkClzlUkga67MB6HdrcorIJlJ95Ps_lfbguuAkPEUuZuKeOhX_y6Dn3xGUE5d0eBNuDFiSve2Nfwt2XHUbrvXZJTd34NfxJJ4Rnzse85Gw2jPEfYzKcYZT2WzRCzKtHDvpM_ewdwvXmvWGTVthprJsv_7mluxg6dDLoePDusjvWb874disRhbPPm1WZ229atiiYvRjdfeP2e8fPxtstjsRugvzw_cnB0fhkIwhLKWK2jCNPS5FTmUF8s4kSUsknryMHH7WqHTaKO6d4kakCNe1N84roY3OPCnkxcLG4h7sVnXlHgArrcD7RmXCI56R0kSZN2mBl5exlWUAL0Yb5Ge95kaOXIXMlk_NFsA-GejiGVLK7m7U68_5MPFy0vu30nFijtIph94XOy5kQZnfcYUN4Nlo3hxnFrVvKlefNzkXiqSAOM8CuN-b--JV43AJQG8NhK2-bJdUiy-dereONOdaPfzvmo9gjxPpp9Dx5DHstutz9wSRUVs87Qb9H_MxE9k
  priority: 102
  providerName: Scholars Portal
Title Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/32041265
https://search.proquest.com/docview/2353578229
https://pubmed.ncbi.nlm.nih.gov/PMC7072275
https://doaj.org/article/2546d4e201444e5e99002234b1714887
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJSqGX0nfdx6JCe3TW1sOyj91tQlJwCG0CuRlJllLD2l52HcLe8jcK_XX9JR3J6-AtPdUHHyRLFp6RZj559A1CH8Hp5CxWPFRW25CVwoZZWeqQq1IlUalk6nm287Pk5JJ9veJXe4gPZ2F80L5W1WGzqA-b6oePrVzWejrEiU3P87mIBCGCT_fRvqB0BNH98puCExPxPsidAqSfui3wdeZ-uQmXsYgSxzHlrMnIEnnC_n95mX8HS46sz_ET9HjrNuLP_fCeoj3TPEMP-0SSm-fo1-kodBGeOx1Sj-DWYnDxsKuHyezq8qrnXqoNvuiT9OAvlenkaoPHvWDZlHjW3poFni8MGDSwcdAWoDzuNyIMzlsA7Pj7pl52bb3GVYPdGWp_nOz33c81dOt__rxAl8dHF_OTcJt3IdSMR12YxhZWHcMzBRAzSVINGJPoyMBnjbQRkhNrOJE0Bc9cWGksp0KKzDoyvJiWMX2JDpq2Ma8R1iWFcskzasF1YUxGmZWpgsuyuGQ6QJ8GGRTLnl6jAFjixFaMxRagmRPQ_TOOFNsXtKvrYqsahaP2L5khDiQyww0YWhg4ZcoleYfFNEAfBvEWMIlc_7Ix7c26IJQ71h9CsgC96sV9_6pBXQIkdhRhZyy7NaC3nqh7q6dv_rvlW_SIOHzvosSTd-igW92Y9-AEdWqCHsyOzs6_TfwmAtxzlk78RPgDhIsQBA
link.rule.ids 230,315,733,786,790,870,891,2115,2236,24346,27957,27958,33780,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQguvBfC00hwTJs4dpwc2cKqhe0KiS7aW-TnbkSTVG0qVE78DSR-Hb-EcdKs0hUXyNHjOI5mPA97_A1Cr8HpZDSUzJdWWZ9qbv1Ua-UzqWUcaCmSBmd7ehKPT-mHM3a2h1h3F6ZJ2lcyH5TzYlDmF01u5aJQwy5PbPhpOuIBJ4Sz4TV0HdYr4b0gvVHACbgxAWvT3CMI6oduE3yVukM37moWRcShTDl70rNFDWT_3_zMq-mSPftzdAd96Wbepp18HaxrOVDfr4A6_vOv3UW3tx4pftuS76E9U95HN9oalZsH6NeklxUJ_SZdVRNcWQzeI3Z00BOONs1bWKfC4Flb_we_y00tlhvcHwWLUuPD6puZ49HcgK0E8wnvnl_UuN3jMHha1dUSf94Ui7oqVjgvsbue3dxU-_3j5wqGbc6VHqLTo_ez0djflnTwFWVB7SehBYVmWCoheo3jREH4SlRggF-BMlwwYg0jIkrA6edWGMsiLnhqHc5eGOkwOkD7ZVWaxwgrHUG7YGlkwSuiVASpFYmEx9JQU-WhNx1zs0WL3JFBxOPkIevLg4cOHecv-zi87aahWp5nW9ZkrmqApoa4-JMaZsCGw8QjKl39eNDTHnrVyU0G69ONL0pTrVcZiZgDFCIk9dCjVo4uP9XJoYf4joTtzGWXAnLTYIBv5eTJf7_5Et0cz6bH2fHk5ONTdIu4bQSXjB4_Q_v1cm2eg69VyxfNyvoDlPQukQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSFd2l4GgmO2SSOvU6OdMuqC2xViVaquER-tlE3yWo3K7Sc-BtI_Dp-CeNkU2UrTs3RdhxHM_bM2J-_Qeg9OJ2MRpL50irrU82tn2qtfCa1HIZaiqTh2Z4eDQ9P6eczdtZL9dWA9pXMB-WsGJT5RYOtnBcq6HBiwfF0xENOCGfBXNvgNroDc5akvUC9WYQTcGVC1kLdYwjsA7cRvkzdwRt3eYti4pimnE3p2aOGtv9_vuZ1yGTPBo0fou_d6FvoyeVgVcuB-nmN2PFGv_cIPdh4pvhj2-QxumXKJ-hum6ty_RT9mfTQkdBu0mU3wZXF4EViVw_rhaub5i29U2HwSZsHCB_kphaLNe73gkWp8X71w8zwaGbAZoIZhXfPL2rc7nUYPK3qaoG_rYt5XRVLnJfYXdNubqz9_fV7Cd0250vP0On408no0N-kdvAVZWHtJ5GFhc2wVEIUOxwmCsJYokIDMguV4YIRaxgRcQLOP7fCWBZzwVPr-PaiWEfxLtopq9LsIax0DOWCpbEF74hSEaZWJBIeSyNNlYc-dALO5i2DRwaRj9OJrK8THtp30r9q43i3m4JqcZ5txJO57AGaGuLiUGqYAVsOA4-pdHnkYb320LtOdzKYp65_UZpqtcxIzByxECGph563unT1qU4XPcS3tGxrLNs1oDsNF_hGV17c-M236N7xwTj7Ojn68hLdJ243wWHSh6_QTr1YmdfgctXyTTO5_gHgcjER
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interventional+Influence+of+the+Intestinal+Microbiome+Through+Dietary+Intervention+and+Bowel+Cleansing+Might+Improve+Motor+Symptoms+in+Parkinson%E2%80%99s+Disease&rft.jtitle=Cells+%28Basel%2C+Switzerland%29&rft.au=Hegelmaier%2C+Tobias&rft.au=Lebbing%2C+Marco&rft.au=Duscha%2C+Alexander&rft.au=Tomaske%2C+Laura&rft.date=2020-02-06&rft.pub=MDPI&rft.eissn=2073-4409&rft.volume=9&rft.issue=2&rft_id=info:doi/10.3390%2Fcells9020376&rft_id=info%3Apmid%2F32041265&rft.externalDBID=PMC7072275
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2073-4409&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2073-4409&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2073-4409&client=summon